First-in-class non-hormonal, oral therapy indicated specifically for cyclic HMB NEWPORT, Ky., Nov. 16 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company ...

Please provide your email address to receive an email when new articles are posted on . Extended tranexamic acid was associated with improved pain scores, flexion and ambulation vs. placebo.

A meta-analysis showed that the use of oral tranexamic acid along with the standard triple combination cream (TCC) reduces melasma severity and recurrence in patients with melasma, without increasing ...

HY-004 provides a new treatment alternative for use in patients on anti-coagulant therapies undergoing dental procedures that have a risk of bleeding or complication HY-004 administered locally had ...

Whether prehospital administration of tranexamic acid increases the likelihood of survival with a favorable functional outcome among patients with major trauma and suspected trauma-induced ...

It wasn’t long ago that tranexamic acid was the reserve of medicine. Wielded by doctors for its blood clotting properties, it was found effective at halting hemorrhages, and is still used as an ...